Differentiating dementias in long-term care patients

Consultant Pharmacist

Volumn 22, Issue 1, 2007, Pages 14-28

  Zanni, Guido R ^a   Wick, Jeannette Y ^b  

^a National Institutes of Health ^*

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Age related cognitive impairment; Alzheimer's disease; Frontotemporal dementia; Lewy Body dementia; Mild cognitive impairment; Mixed dementia; Vascular dementia

Indexed keywords

ADULT; AGED; ALZHEIMER DISEASE; CLINICAL FEATURE; COGNITION; COMORBIDITY; DEMENTIA; DISEASE ASSOCIATION; DISEASE COURSE; EXTRAPYRAMIDAL SYMPTOM; FRONTOTEMPORAL DEMENTIA; HUMAN; LANGUAGE DISABILITY; LEWY BODY; LONG TERM CARE; MEMORY DISORDER; MINI MENTAL STATE EXAMINATION; MULTIINFARCT DEMENTIA; PARKINSON DISEASE; RESTLESSNESS; REVIEW; VISUAL HALLUCINATION;

EID: 33846440519     PISSN: 08885109     EISSN: None     Source Type: Journal    
DOI: 10.4140/TCP.n.2007.14     Document Type: Review

References (39)

1. Pokorski RJ. Differentiating age-related memory loss from early dementia. J Insur Med 2002; 34:100-13.
2. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state." A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-98.
3. Finkel S. Screening for dementia in primary care practice. A Medscape CE, available at http://www.medscape.com/viewarticle/423409_3. Accessed October 2, 2006.
4. Solomon PR, Pendlebury WW. Recognition of Alzheimer's disease: the 7-Minute Screen. Fam Med 1998;30:265-71.
5. Borson S, Scanlan JM, Chen P et al. The Mini-Cog as a screen for dementia: validation in a population-based sample. J Am Geriatr Soc 2003;51:1451-4.
6. Borson S, Scanlan J, Brush M et al. The Mini-Cog: a cognitive 'vital signs' measure for dementia screening in multi-lingual elderly. Int J Geriatr Psychiatry 2000;15:1021-7.
7. Santacruz KS, Swagerty D. Early diagnosis of dementia. Am Fam Physician 2001;63:703-13: 717-8.
8. Mintzer J, Burns A. Anticholinergic side-effects of drugs in elderly people. J R Soc Med 2000;93:457-62.
9. Crum RM, Anthony JC, Bassett SS et al. Population-based norms for the mini-mental state examination by age and educational level. JAMA 1993;18:2386-91.
10. Milisen K, Braes T, Fick DM, et al. Cognitive assessment and differentiating the 3 Ds (dementia, depression, delirium). Nurs Clin North Am 2006;41:1-22
11. Gauthier S, Reisberg B, Zaudig M et al. Mild cognitive impairment. Lancet 2006;367:1262-70.
12. Petersen RC, Smith GE, Waring SC et al. Mild cognitive impairment: clinical characterization and outcome. Arch Neurol 1999;56:303-8.
13. Honig L. Recognition of vascular dementia, dementia with Lewy bodies, and frontotemporal dementia. Available at http://ci.columbia.edu/c1182/web/sect_5/ cl_182_s5_2.html. Accessed October 12, 2006.
14. Hebert LE, Scherr PA, Bienias JL et al. Alzheimer disease in the U.S. population: prevalence estimates using the 2000 census. Arch Neurol 2003;60:1119-22.
15. Evans D, Funkenstein HH, Albert M et al. Prevalence of Alzheimer's disease in a community population of older persons: higher than previously reported. JAMA 1989;262:2551-6.
16. Larson EB, Shadlen MF, Wang L et al. Survival after initial diagnosis of Alzheimer disease. Ann Intern Med 2004;140:501-9.
17. Alzheimer's Association. Statistics about Alzheimer's Disease. Available at http://www. alz.org/AboutAD/statistics.asp. Accessed October 15, 2006.
18. Larson EB, Shadlen MF, Wang L et al. Survival after initial diagnosis of Alzheimer disease. Ann Intern Med 2004;140:501-9.
19. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th edition. Wahsington, DC: American Psychiatric Association 1994.
20. Alagiakrishnan K, Masaki M. Vascular dementia. http://www.emedicine.com/ med/topic 3150.htm. Accessed September 27, 2006.
21. Langa KM, Foster NL, Larson EB. Mixed dementia: emerging concepts and therapeutic implications. JAMA 2004;292:2901-8.
22. Nagata K, Maruya H, Yuya H et al. Can PET data differentiate Alzheimer's disease from vascular dementia? Ann NY Acad Sci 2000;903:252-61.
23. Graham NL, Emery T, Hodges JR. Distinctive cognitive profiles in Alzheimer's disease and subcortical vascular dementia. J Neurol Neurosurg Psychiatry 2004;75:61-71.
24. Allan LM, Ballard CG, Burn DJ et al. Prevalence and severity of gait disorders in Alzheimer's and non-Alzheimer's dementias. J Am Geriatr Soc 2005;53:1681-7.
25. Chow T. A dementia by any other name: what if it is not Alzheimer's disease? (Atypical dementias). Alzheimer's Care Q 2005;6:215-25.
26. Bradely BF. Dementia with Lewy bodies. Dementia continuum: lifelong learning in neurology 2004;10:81-112. Available at:http: //www.lewybodydementia. org/docs/DLB-BoeveContinuum04. pdf
27. Mosimann UP, McKeith IG. Dementia with Lewy bodies-diagnosis and treatment. Swiss Med Wkly 2003;133:131-42.
28. McKeith IG, Galasko D, Kosaka K et al. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the Consortium on DLB International Workshop. Neurology 1996;47: 1113-24.
29. Lewy Body Dementia Organization. LBD Symptoms. Available at http://www.lewybody-dementia.org/symptoms.php. Accessed October 4, 2006
30. Walker Z, Costa D, Walker R et al. Differentiation of dementia with Lewy Bodies from Alzheimer's disease using a domaminergic presynaptic ligand. J Neuro Neurosurg Psychiatry 2002;73:134-40.
31. McKeith IG, Dickson DW, Lowe J et al. Consortium on DLB. Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology 2005;65:1863-72.
32. National Institute of Neurological Disorders and Stroke. NINDS frontotemporal dementia information page. Available at http://www. ninds.nih.gov/disorders/picks/picks.htm. Accessed October 4, 2006.
33. University of California, San Francisco Memory and Aging Center. Frontotemporal dementia (FTD). Available at http://memory. ucsf.edu/Education/ Disease/ftd.html.Accessed October 10, 2006.
34. Snowden JS, Neary D. Neuropsychiatric aspects of frontotemporal dementias. Curr Psychiatry Rep 1999;1:93-8.
35. Zekry D, Hauw JJ, Gold G. Mixed dementia: epidemiology, diagnosis, and treatment. J Am Geriatr Soc 2002;50:1431-8.
36. Rockwood K, Macknight C, Wentzel C et al. The diagnosis of "mixed" dementia in the Consortium for the Investigation of Vascular Impairment of Cognition (CIVIC). Ann NY Acad Sci 2000;903:522-8.
37. Erkinjuntti T, Kurz A, Gauthier S et al. Efficacy of galantamine in probable vascular dementia and Alzheimer's disease combined with cerebrovascular disease: a randomised trial. Lancet 2002;359:1283-90.
38. Kumar V, Anand R, Messina J et al. An efficacy and safety analysis of Exelon in Alzheimer's disease patients with concurrent vascular risk factors. Eur J Neurol 2000;7: 159-69.
39. Haggerty JJ Jr, Golden RN, Evans DL et al. Differential diagnosis of pseudodementia in the elderly. Geriatrics 1988;43:61-9, 72, 74.